Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

DOI: 10.1186/s13195-019-0485-0

Keywords: Alzheimer’s Disease, Amyloidβ Peptides, Aβ42/40 ratio, Biomarkers, Cerebrospinal Fluid

Full-Text   Cite this paper   Add to My Lib

Abstract:

CSF biomarkers to distinguish cases with ADD from cases with non-AD

Full-Text